Quality by digital design in action : a workflow for crystallisation and isolation
Houson, Ian and Siddique, Humera and Chong, Magdalene W.S. and Robertson, Murray and Turner, Alice J. and Nordon, Alison and Osman, Amal and Galindo, Amparo and Dunn, Andrew S. and Johnston, Blair and Benyahia, Brahim and Brown, Cameron J. and Mustoe, Chantal L. and Price, Chris J. and Reilly, Chris D. and Adjiman, Claire S. and Jackson, George and Prasad, Elke and Halbert, Gavin and Feilden, Helen and Sefcik, Jan and McGinty, John and Robertson, John and Smith, Kenneth and Al-Attili, Mais and McGowan, Mark and Siddique, Mariam and Pathan, Momina and Rajoub, Nazer and Hamilton, Niki and Feeney, Rachel and Brown, Scott and Urwin, Stephanie J. and Bernet, Thomas and Pickles, Thomas and Li, Wei and Florence, Alastair J. (2025) Quality by digital design in action : a workflow for crystallisation and isolation. International Journal of Pharmaceutics, 686. 126343. ISSN 1873-3476 (https://doi.org/10.1016/j.ijpharm.2025.126343)
Preview |
Text.
Filename: Houson-etal-IJP-2025-Quality-by-digital-design-in-action.pdf
Final Published Version License:
Download (2MB)| Preview |
Abstract
This paper exemplifies a Quality by Digital Design (QbDD) workflow for the crystallisation and isolation of active pharmaceutical ingredients (APIs). QbDD uses a digital first approach to improve manufacturability and sustainability whilst assuring product quality within practical constraints. This study uses three exemplar compounds (ibuprofen, lamivudine, and AZD0837), each of which presents a different challenge for crystallisation; these include agglomeration, solid state form, and slow growth rates, respectively. These cases are used to evaluate the benefits of the QbDD approach and identify gaps for future research. Results of this work show that the QbDD workflow reduces the number of physical experiments by 28% and the API material usage by 52–65% when compared to comparable API development processes not using this approach. This approach provides a route to practically implement and exploit the benefits of digital tools and overcome digital skill shortages. By exploiting digital tools for process simulation and optimisation, the workflow improves efficiency, even in complex cases where multiple workflow iterations are required. This workflow, therefore, paves the way for more sustainable and cost-effective API production and it promotes future standardisation of digital design in pharmaceutical development.
ORCID iDs
Houson, Ian
ORCID: https://orcid.org/0009-0004-9836-6293, Siddique, Humera
ORCID: https://orcid.org/0000-0002-0770-7362, Chong, Magdalene W.S.
ORCID: https://orcid.org/0000-0002-0319-5769, Robertson, Murray
ORCID: https://orcid.org/0000-0001-9543-7667, Turner, Alice J.
ORCID: https://orcid.org/0000-0002-5323-9221, Nordon, Alison
ORCID: https://orcid.org/0000-0001-6553-8993, Osman, Amal, Galindo, Amparo, Dunn, Andrew S.
ORCID: https://orcid.org/0000-0002-8417-8468, Johnston, Blair
ORCID: https://orcid.org/0000-0001-9785-6822, Benyahia, Brahim, Brown, Cameron J.
ORCID: https://orcid.org/0000-0001-7091-1721, Mustoe, Chantal L.
ORCID: https://orcid.org/0000-0002-8404-2229, Price, Chris J.
ORCID: https://orcid.org/0000-0002-0790-6003, Reilly, Chris D., Adjiman, Claire S., Jackson, George, Prasad, Elke
ORCID: https://orcid.org/0000-0002-5412-9374, Halbert, Gavin, Feilden, Helen
ORCID: https://orcid.org/0009-0006-2122-3301, Sefcik, Jan
ORCID: https://orcid.org/0000-0002-7181-5122, McGinty, John
ORCID: https://orcid.org/0000-0002-8166-7266, Robertson, John
ORCID: https://orcid.org/0000-0002-2191-1319, Smith, Kenneth, Al-Attili, Mais
ORCID: https://orcid.org/0000-0002-1192-5020, McGowan, Mark, Siddique, Mariam
ORCID: https://orcid.org/0000-0002-3054-7192, Pathan, Momina, Rajoub, Nazer
ORCID: https://orcid.org/0000-0002-1373-3022, Hamilton, Niki
ORCID: https://orcid.org/0000-0002-5889-863X, Feeney, Rachel, Brown, Scott
ORCID: https://orcid.org/0000-0003-4908-7058, Urwin, Stephanie J.
ORCID: https://orcid.org/0000-0002-9092-0200, Bernet, Thomas, Pickles, Thomas
ORCID: https://orcid.org/0009-0006-3377-3124, Li, Wei and Florence, Alastair J.
ORCID: https://orcid.org/0000-0002-9706-8364;
-
-
Item type: Article ID code: 94625 Dates: DateEvent25 December 2025Published1 November 2025Published Online29 October 2025AcceptedSubjects: Medicine > Pharmacy and materia medica > Pharmaceutical technology Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Faculty of Science > Pure and Applied Chemistry
Strategic Research Themes > Measurement Science and Enabling Technologies
Strategic Research Themes > Advanced Manufacturing and Materials
Technology and Innovation Centre > Continuous Manufacturing and Crystallisation (CMAC)
Faculty of Engineering > Chemical and Process Engineering
Technology and Innovation Centre > BionanotechnologyDepositing user: Pure Administrator Date deposited: 03 Nov 2025 12:42 Last modified: 11 Jan 2026 01:42 URI: https://strathprints.strath.ac.uk/id/eprint/94625
Tools
Tools






